Beam Therapeutics (BEAM) Preferred Shares Issued (2019)

Beam Therapeutics (BEAM) reported Preferred Shares Issued of $37.9 million for Q1 2019.

Beam Therapeutics (BEAM) Preferred Shares Issued (2019) Analysis & Trends

Beam Therapeutics (BEAM) has 1 years of Preferred Shares Issued data on file, last reported at $37.9 million in Q1 2019.

Preferred Shares Issued for Q1 2019 came in at $37.9 million, changed N/A year-over-year; the trailing twelve-month figure through Dec 2019 was $37.9 million (changed N/A YoY), and the FY2019 annual result was $37.9 million, changed N/A from the prior year.
Preferred Shares Issued held at $37.9 million in Q1 2019 per BEAM's latest filing.
Over five years, Preferred Shares Issued peaked at $37.9 million in Q1 2019 and troughed at $37.9 million in Q1 2019.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Preferred Shares Issued (Qtr)
1	Alterity Therapeutics	925,601.88 Bn	925,601.85 Bn	-	-
2	Belite Bio	58,560.00 Bn	58,560.00 Bn	-	-
3	Quantum Biopharma	17,284.41 Bn	17,284.40 Bn	-	-
4	Legend Biotech	2,809.00 Bn	2,808.71 Bn	242.10 Mn	-
5	Evaxion A	1,334.43 Bn	1,334.42 Bn	-	-
6	Akari Therapeutics	1,312.27 Bn	1,312.26 Bn	-	-
7	Psyence Biomedical	212.16 Bn	212.16 Bn	-	-
8	Vertex Pharmaceuticals	114.83 Bn	107.58 Bn	2.59 Bn	-
9	Abivax	91.96 Bn	91.96 Bn	-	-
10	Beam Therapeutics	3.53 Bn	3.53 Bn	-	-

Download Data

Date	Value
Mar 31, 2019	37.90 Mn
Mar 31, 2019	37.90 Mn